人营养类胡萝卜素的全球市场 (2022-2028年):各类型 (虾青素、β-胡萝卜素)、用途 (营养补充品、功能性营养) 的规模、占有率、成长分析、预测

Global Carotenoids In Human Nutrition Market Size, Share, Growth Analysis, By Type(Astaxanthin, Beta-Carotene), By Application(Dietary Supplements, Functional Nutrition) - Industry Forecast 2022-2028

出版日期: 2023年04月13日 | 出版商:

SkyQuest | 英文 221 Pages | 商品交期: 3-5个工作天内

价格

简介目录

人营养类胡萝卜素的市场规模，2021年是30亿1,000万美元，2022年是32亿2,000万美元，从2023年到2030年的预测期间中预计以7.1％的年复合成长率发展，2030年成长到59亿8,000万美元的规模成长。

由于天然色素和营养补充品的消费者需求高涨，市场预计大幅成长。类胡萝卜素是许多水果和蔬菜中包含的天然色素，有抗氧化作用。免疫功能的提高和降低慢性疾病的风险等，类胡萝卜素相关的健康效果的认识高涨，推动市场成长。

本报告提供全球人营养类胡萝卜素的市场调查，市场概要，市场的各种影响因素的分析，技术、革新趋势，法律制度，市场规模的变化、预测，各种区分、各地区的明细，竞争情形，主要企业简介等彙整资讯。

市场概要
市场规模
市场动态
促进因素
机会
阻碍因素
课题
主要市场洞察
技术分析
价格分析
供应链分析
价值链分析
市场生态系统
IP分析
贸易分析
Start-Ups分析
原料分析
革新矩阵
开发中产品的分析
宏观经济指标
主要投资分析
主要成功因素
竞争的程度
市场动态及预测
市场动态
促进因素
机会
阻碍因素
课题
法规情形
波特分析
未来阻碍相关Skyquest的特别洞察

全球人营养类胡萝卜素市场:各类型

市场概要
虾青素
β胡萝卜素
叶黄素
茄红素
角黄素
玉米黄质
其他

全球人营养类胡萝卜素市场:各用途

市场概要
营养补充品
功能性营养
运动营养
婴儿营养
其他
全球人营养类胡萝卜素市场:各地区
市场概要
北美
美国
加拿大
欧洲
德国
西班牙
法国
英国
其他的欧洲地区
亚太地区
中国
印度
日本
韩国
其他的亚太地区
南美
巴西
其他南美国家
中东、非洲
GCC各国
南非
其他的中东、非洲地区
竞争情形
主要5家公司的比较
主要企业的市场上的地位
主要企业的采用策略
主要成功策略
市场上最近的活动
主要企业的市场占有率
主要企业简介
BASF S.E.
GSK,
Roche
Novo Nordisk
Koninklijke DSM N.V.
Givaudan Group
Dr. Reddy's Laboratories
Cipla
Sun Pharmaceutical

简介目录

Product Code: SQSG30I2032

Global Carotenoids in Human Nutrition Market size was valued at USD 3.01 billion in 2021 and is poised to grow from USD 3.22 billion in 2022 to USD 5.98 billion by 2030, growing at a CAGR of 7.1% in the forecast period (2023-2030).

The global carotenoids in human nutrition market is expected to experience significant growth due to the increasing consumer demand for natural colorants and dietary supplements. Carotenoids are natural pigments that are found in many fruits and vegetables, and are known for their antioxidant properties. They are commonly used in food, dietary supplements, and pharmaceuticals. The rising awareness of the health benefits associated with carotenoids, such as improved immune function and reduced risk of chronic diseases, is driving the market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of Carotenoids in Human Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Carotenoids in Human Nutrition Market is segmented based on Type, Application, and Region. Based on the Type, the Global Carotenoids in Human Nutrition Market are segmented as Astaxanthin, Beta-Carotene, Lutein, Lycopene, Canthaxanthin, Zeaxanthin, and Others. Based on the Application, the Global Carotenoids in Human Nutrition Market is segmented as Dietary Supplements, Functional Nutrition, Sports Nutrition, and Infant Nutrition. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Dietary supplements in North America frequently incorporate synthetic carotenoids such as -carotene, -carotene, lutein, zeaxanthin, lycopene, and -cryptoxanthin. Nonetheless, there is an increasing demand for naturally sourced carotenoids in the pharmaceutical industry, and opportunities for growth in high-potential markets are expected to drive global demand for carotenoids. This highlights the need to explore natural sources of carotenoids for use in pharmaceutical applications.

Restrain

The production of carotenoids through chemical synthesis or plant extraction is facing challenges due to low yields, leading to high production costs. In addition, temporary border closures in some countries have restricted the export and import of non-essential products, which is exacerbating the hindrances to the growth of this industry.

Trend

The pharmaceutical and cosmetics industries are increasingly utilizing carotenoids as nutraceuticals due to the growing awareness of their health benefits. It is anticipated that there will be a rise in the use of synthetic sources of carotenoids in the coming years.